spot_img
Thursday, November 30, 2023

Alantra adds Legal director from Prisa

Alantra has hired Ana Montes Ayuso, who joins from Prisa, to be a new director in the firm´s Legal department

-

She jumped to the company world in 2018 when she joined Prisa as an in-house counsel. Now she leaves Prisa to be the new director in Alantra´s Legal department, a global alternative asset management, investment banking, and credit portfolio advisory firm focusing on providing high value-added services to companies, families, and investors operating in the mid-market segment. The Group has over 540 professionals across Europe, the US, Latin America, and Asia.

Ana prepared for the State Attorney Public Competition Examination. She started her professional career at Gómez-Acebo & Pombo as a Corporate junior associate in 2009 and she remained there until 2014. Then, she joined Linklaters as Corporate managing associate. During her time at the magic circle law firm, she specialised in advising industrial and financial clients on M&A and restructuring operations, both national and international, participating in all phases, from the due diligence process, coordinating various departments, to the preparation and negotiation of contracts (SPAs, SHAs, JVAs, TSAs, etc.) and other ancillary documentation (corporate agreements).

She is a Law & Business Administration graduate from the Universidad Pontificia Comillas (ICADE-E3) with a stay at the Université Catholique de Louvain (UCLouvain).

- Advertisement -spot_img
- Advertisement -spot_img

MOST READ NEWS

Multi-law firm advice on Brown‑Forman´s acquisition of Gin Mare

Brown‑Forman Corporation has announced its agreement to purchase the Gin Mare brands from Vantguard and MG Destilerías. Upon completion of the transaction, Brown‑Forman will...

CC advises QuironSalud on sale of hospital in Peru

The divested portfolio consists of QuironSalud's stake in the flagship hospital Clínica Ricardo Palma located in Lima. Entities of the Verme family, who currently...

Evergreen advises Tresmares Capital on its entry into Proteos Biotech

Proteos Biotech specialises in producing recombinant enzymes whose products have high-quality standards backed by various certifications and scientific support. The company develops exclusive assets...
spot_img
spot_img
spot_img
spot_img
- Advertisement -spot_img
error: